Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday. The ...

Aug. 19, 2024 — Two new studies are pointing the way toward round-the-clock personalized care for people with Parkinson's disease through an implanted device that can treat movement problems ...

Arctic therapeutics raises funding from EIC Fund, Kaldbakur, and Sanos Group to advance its dementia treatment, AT-001, and acne drug, AT-004. The company aims to transform the treatment landscape for ...

However, how iron deposition influences brain network remains to be elucidated. Methods: We recruited 16 Parkinson’s disease (PD), 8 multiple system atrophy (MSA) and 7 progressive supranuclear palsy ...

These electrodes connect to a device (similar to a pacemaker) placed under the skin in ... induced Parkinson’s-like conditions, which may not fully replicate human disease complexity.

Attention deficit hyperactivity disorder (ADHD) and Parkinson’s disease are distinct neurological conditions. They typically onset at different life stages: ADHD in childhood and Parkinson’s ...

Babies or young children may develop a number of warning signs on their skin including blue, grey, pale or blotching on their skin, lips or tongue. It may be easier to spot these signs on the ...

Get Instant Summarized Text (Gist) A wireless photothermal deep brain stimulation (DBS) nanosystem, ATB NPs, has been developed to treat Parkinson's disease by targeting dopaminergic neurons. This ...